Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zenas Z N Yiu

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Expert Review of Clinical Pharmacology|December 17, 2025
Is there a link between cholesterol-lowering medications and atopic dermatitis?John Tetteh, Zenas Z N Yiu
American Journal of Clinical Dermatology|March 1, 2016
Novel Oral Therapies for Psoriasis and Psoriatic ArthritisZenas Z N Yiu, Richard B Warren
Expert Opinion on Investigational Drugs|January 3, 2017
The potential utility of tildrakizumab: an interleukin-23 inhibitor for the treatment of psoriasisZenas Z N Yiu, Richard B Warren
Immunotherapy|February 26, 2015
Efficacy and safety of emerging immunotherapies in psoriasisZenas Z N Yiu, Richard B Warren
Clinical Pharmacology and Therapeutics|July 13, 2017
Raising Standards for the Evaluation of Future Psoriasis Therapeutics: A Critical ChecklistZenas Z N Yiu, Richard B Warren
American Journal of Clinical Dermatology|July 22, 2021
Cardiovascular Safety of Biologics Targeting Interleukin (IL)-12 and/or IL-23: What Does the Evidence Say?Marianne de Brito, Zenas Z N Yiu
The Journal of Allergy and Clinical Immunology|May 27, 2024
Genetically proxied IL-6 receptor inhibition is associated with increased risk of atopic dermatitisSizheng Steven Zhao, Zenas Z N Yiu
Expert Review of Clinical Immunology|November 13, 2015
Interleukin 17-A inhibition in the treatment of psoriasisZenas Z N Yiu, Christopher E M Griffiths
Expert Opinion on Drug Safety|April 2, 2020
How is safety of dermatology drugs assessed: trials, registries, and spontaneous reportingLeila Asfour, Zenas Z N Yiu, Richard B Warren
Clinical Rheumatology|January 20, 2025
External validation of the accuracy of cardiovascular risk prediction tools in psoriatic disease: a UK Biobank studyDavid M Hughes, Zenas Z N Yiu, Sizheng Steven Zhao
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Expert Review of Clinical Pharmacology|December 17, 2025
Is there a link between cholesterol-lowering medications and atopic dermatitis?John Tetteh, Zenas Z N Yiu
American Journal of Clinical Dermatology|March 1, 2016
Novel Oral Therapies for Psoriasis and Psoriatic ArthritisZenas Z N Yiu, Richard B Warren
Expert Opinion on Investigational Drugs|January 3, 2017
The potential utility of tildrakizumab: an interleukin-23 inhibitor for the treatment of psoriasisZenas Z N Yiu, Richard B Warren
Immunotherapy|February 26, 2015
Efficacy and safety of emerging immunotherapies in psoriasisZenas Z N Yiu, Richard B Warren
Clinical Pharmacology and Therapeutics|July 13, 2017
Raising Standards for the Evaluation of Future Psoriasis Therapeutics: A Critical ChecklistZenas Z N Yiu, Richard B Warren
American Journal of Clinical Dermatology|July 22, 2021
Cardiovascular Safety of Biologics Targeting Interleukin (IL)-12 and/or IL-23: What Does the Evidence Say?Marianne de Brito, Zenas Z N Yiu
The Journal of Allergy and Clinical Immunology|May 27, 2024
Genetically proxied IL-6 receptor inhibition is associated with increased risk of atopic dermatitisSizheng Steven Zhao, Zenas Z N Yiu
Expert Review of Clinical Immunology|November 13, 2015
Interleukin 17-A inhibition in the treatment of psoriasisZenas Z N Yiu, Christopher E M Griffiths
Expert Opinion on Drug Safety|April 2, 2020
How is safety of dermatology drugs assessed: trials, registries, and spontaneous reportingLeila Asfour, Zenas Z N Yiu, Richard B Warren
Clinical Rheumatology|January 20, 2025
External validation of the accuracy of cardiovascular risk prediction tools in psoriatic disease: a UK Biobank studyDavid M Hughes, Zenas Z N Yiu, Sizheng Steven Zhao
Pageof 6